?
What is the therapeutic window for [LRRK2](/entities/lrrk2) kinase inhibition in PD patients?
active
open question
Created: 2026-04-25T20:27:36
By: backfill_open_questions
Quality:
50%
✓ SciDEX
ID: open_question-2b200597-20fa-47d4-bb9a-08
Open Question
open
Wiki: diseases-parkinson-disease
What is the therapeutic window for [LRRK2](/entities/lrrk2) kinase inhibition in PD patients?
Importance Elo
1500
Field Rank
Rank #177 in diseases
Tractability
0.50
Potential Impact
0.50
Evidence Summary
Extracted from wiki page diseases-parkinson-disease
Secondary Market
No secondary market activity yet. Learn about share issuance →
Share Holder Leaderboard
No shares issued yet.
Evidence Bearing On This Question
No cross-references found yet. Evidence matching runs daily.
Pairwise Tournament History
No pairwise judgments recorded yet.
Derived Hypotheses And Proposals
No derived artifacts linked yet.
Related Entities
▸Metadata
| status | open |
| _origin | {'url': None, 'type': 'internal', 'tracked_at': '2026-04-26T03:27:36.801351'} |
| field_tag | diseases |
| source_id | diseases-parkinson-disease |
| sub_field | parkinson-disease |
| source_kind | wiki |
| question_hash | a5bca27ef5a0d0dac0939c3898cd3794d24da1ba0501b4ba0d15d60fa9b319df |
| question_text | What is the therapeutic window for [LRRK2](/entities/lrrk2) kinase inhibition in PD patients? |
| importance_elo | 1500 |
| _schema_version | 1 |
| evidence_summary | Extracted from wiki page diseases-parkinson-disease |
| tractability_score | 0.5 |
| potential_impact_score | 0.5 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
1
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.